Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases



Similar documents
TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298

Nuevas tecnologías basadas en biomarcadores para oncología

School of Nursing. Presented by Yvette Conley, PhD

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

Genomic Medicine Education Initiatives of the College of American Pathologists

A leader in the development and application of information technology to prevent and treat disease.

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Core Facility Genomics

Future Oncology: Technology, Products, Market and Service Opportunities

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)

Genomics in Hematology

TRACKS GENETIC EPIDEMIOLOGY

Biological Sciences Initiative. Human Genome

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

The Human Genome Project. From genome to health From human genome to other genomes and to gene function Structural Genomics initiative

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

2019 Healthcare That Works for All

Relative Risk (Sokal & Hasford): Relationship with Treatment Results. Michele Baccarani

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

Roche Position on Human Stem Cells

Stem Cell Quick Guide: Stem Cell Basics

Control of Gene Expression

Biochemistry Major Talk Welcome!!!!!!!!!!!!!!

Innovation Platform: Sudden Cardiac Death

Human Genome Organization: An Update. Genome Organization: An Update

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

Computational Biomarker Discovery in the Big Data Era: from Translational Biomedical Informatics to Systems Medicine

ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)

The National Institute of Genomic Medicine (INMEGEN) was

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center

Fulfilling the Promise

MUTATION, DNA REPAIR AND CANCER

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

Breast and Lung Cancer Biomarker Research at ASCO: Changing Treatment Patterns

STEM CELL FELLOWSHIP

THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS

Avances en biología molecular en gliomas de alto grado

IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS

Support structure for genetic material

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

How Can Institutions Foster OMICS Research While Protecting Patients?

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association

White paper Evaluation of BRAF (V600E) Mutation by Immunohistochemical Staining with anti-braf V600E (VE1) Antibody: A Comparison with Sanger

BIOLOGICAL SCIENCES REQUIREMENTS [63 75 UNITS]

CCR Biology - Chapter 9 Practice Test - Summer 2012

Acute Myeloid Leukemia Therapeutics Market to 2020

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

Autoimmunity and immunemediated. FOCiS. Lecture outline

Gruppi di lavoro Biologia Cellulare e Molecolare Biotecnologie e Differenziamento. Università degli Studi di Napoli Federico II BIOGEM.

Personalized medicine in China s healthcare system

Next Generation Sequencing

Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider

Chapter 5: Organization and Expression of Immunoglobulin Genes

Introduction To Epigenetic Regulation: How Can The Epigenomics Core Services Help Your Research? Maria (Ken) Figueroa, M.D. Core Scientific Director

Next Generation Sequencing: Technology, Mapping, and Analysis

Evaluation of focal adhesions as new therapeutic targets in acute myeloid leukemia

Dal germinale al somatico nella identificazione di tumori ereditari

The following information is only meant for people who have been diagnosed with advanced non-small cell

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare

Regulatory Issues in Genetic Testing and Targeted Drug Development

Dr Alexander Henzing

IV Molecular Cytopathology Focus on Next Generation Sequencing in Cytopathology

Cancer Patients Urgently Need Effective, Genetically-Targeted Treatments

RNAseq / ChipSeq / Methylseq and personalized genomics

Corporate Medical Policy

Exelixis Showcases R&D Pipeline at JPMorgan Healthcare Conference

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

FACULTY OF MEDICAL SCIENCE

For additional information on the program, see the current university catalog.

Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives

The National Centre for Biomedical Engineering Science

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Introduction to Pathology and Diagnostic Medicine

Developments in Biomarker Identification and Validation for Lung Cancer

Craig Hallum Conference Investor Presentation

Targeted Therapy What the Surgeon Needs to Know

International symposium on: The Impact of Genomic Deep Sequencing on

Stakeholder Insight: Acute Leukemias - Reaching the Limits of Cytotoxic Chemotherapy

dixa a data infrastructure for chemical safety Jos Kleinjans Dept of Toxicogenomics Maastricht University

Pharmacology skills for drug discovery. Why is pharmacology important?

Transcription:

The International School of Advanced Molecular BioMedicine Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases AciTrezza (Catania), Italy, October 2nd-6th, 2009 Hieronymus Bosch: Garden of Earthly Delights, 1504

october 2nd, 2009 09.00-10.00 Welcome and Introduction A Recca Rettore, Università degli Studi di Catania F Basile Preside, Facoltà di Medicina e Chirurgia G Catania Presidente, Corso di Laurea in Medicina e Chirurgia F Stivala Direttore, Dipartimento di Scienze BioMediche F Cicirata M Purrello C Di Pietro Pieter the Elder Bruegel: Netherlandish Proverbs, 1559

october 2nd, 2009 10.00 11.00 Opening Genomic Variation in Humans KH Grzeschik 11.00-11.30 11.30-12.30 New Methods of Drug Delivery for Optimizing PharmacoKinetics and Minimizing Side Effects M Magnani 12.30 13.00 Discussion 14.30-16.00 Workshop Applied Biosystems Solid 3 Plus From Gigabases to Terabytes: The New Era for Genomics and Transcriptomics E Dallepiatte Methods to Detect Known and Unknown Single Nucleotide Polymorphisms (SNPs) E Tosi 16.00-17.00 Workshop Transgenomic DHPLC: the Unique Analytical and Preparative Platform to Complete all Genetic and Microbiological Investigations M Sbalzarini

october 3rd, 2009 09.00-10.00 Translational Medicine 1: Examples from Bench to Bedside G Pellegrini 10.00-11.00 Mesenchymal Models of Differentiation V Sottile 11.00-11.30 11.30-12.30 Mediated Intracellular Delivery of Therapeutic Molecules R Sánchez-Martín 12.30-13.00 Discussion 15.00-16.00 DNA Methylation from Benchwork to Patient s Bed M Romani 16.00-17.00 Diagnostic Application Of PNA Technology JJ Díaz-Mochón

october 4th, 2009 09.00-10.00 Interfacing Whole Cells with PNA-Encoded Peptide Libraries JJ Díaz-Mochón 10.00-11.00 Translational Medicine 2: Application of New European Rules to Regenerative Medicine G Pellegrini 11.00-11.30 11.30-12.30 DNA Methylation as a Cancer Biomaker and as a Diagnostic Aid M Romani 12.30-13.00 Discussion 15.00-16.00 Classification of Colorectal Cancer G Lanza 16.00 Communications Expression Profile and Specific Network Features of the Apoptotic Machinery Explain Relapse of Acute Myeloid Leukemia after Chemotherapy R Angelica Analysis of EGFR Overexpression and EGFR Gene Amplification in 34 Patients with Glioblastoma. An Immunohistochemical and FISH Study R Caltabiano

Mappatura di Epitopi Conformazionali di Coxsackie Virus di Ggruppo B Tramite Tecnologia del Phage-Display S Carnazza Dynamic Expression of Cx47 in Mouse Brain Development and in the Cuprizone Model of Myelin Plasticity Catania Pathogenomics of the Human Apoptotic Machinery: Identification and Prioritization of New Candidate Genes for Diabetes and Network Analysis LR Duro Thyrospheres: an in Vitro Model for Human Thyroid Cancer F Frasca 17.00-17.30 Molecular Markers of Oocytes Quality MR Guglielmino MicroRNA Expression Profile in Colorectal Carcinoma after Chemotherapy A Majorana Insulin Receptors and Signaling in Pancreatic Alpha Cells T Maniscalchi Role of Interferon Regulatory Factor 5 (IRF-5) in Chronic Myeloid Leukemia L Manzella Biomarkers nel Carcinoma del Colon-Retto G Piccolo Characterization of a Chimeric Mosaic Structure Carrying Erm(B), Tet(O) and Aad(E) Genes in S.Agalactiae M Santagati 20.30 Social Dinner

october 5th, 2009 09.00 10.00 Study of Microsphere-Mediated Cellular Delivery by Chemical, Microscopic and Gene Expression Analysis R Sánchez-Martín 10.00 11.00 Stem Cells in Adults Tissues Example of Use to Study Gene Regulation and Disease V Sottile 11.00 11.30 11.30 12.30 Molecular Prognostic and Predictive Factors in Colorectal Cancer G Lanza 12.30 13.30 Discussion 15.00 16.00 Workshop M-Medical Licor 4300 System and its Application to Genetic Screening of Fabry Disease M Petilli D Nuzzo, IBIM-CNR Palermo 16.00 17.00 Workshop Illumina Innovations in Genomic Analysis: Downstream Analysis of Illumina Sequencing Data M Cappelletti

october 6th, 2009 09.00 10.00 An Open Dialogue Between Law and Biomedical Science: Experience, Objectives and Multidisciplinary Approach of Bios & Law Research Centre S Randazzo 10.00 11.00 Methods of Prediction of Human Splicing F Piva 11.00 11.30 11.30 12.30 Final X-Linked Developmental Defects: How to Survive Lethal Mutations? KH Grzeschik 13.30 14.30 CFU Course Exanimations 15.00 17.00 PhD Final Examinations 17.00 17.30